Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2023-12-20 19:13 Tx date 2023-12-19 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+10,000 vol |
37,017 | |
Filed 2023-09-28 12:01 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
11 - Acquisition or disposition carried out privately
|
+422,732 vol |
422,732 | |
Filed 2023-09-28 12:00 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Warrants Private Offering Sept 2023
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-09-28 12:00 Tx date 2023-09-25 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
11 - Acquisition or disposition carried out privately
|
$1,250,001
+676,371 vol $1.85 each |
1,188,076 | |
Filed 2023-07-14 19:51 Tx date 2023-07-14 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+12,500 vol |
27,017 | |
Filed 2023-07-14 19:30 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+511,705 vol |
511,705 | |
Filed 2023-07-14 19:30 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-3,070,229 vol |
0 | |
Filed 2023-07-14 19:29 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
+124,344 vol |
124,344 | |
Filed 2023-07-14 19:29 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
37 - Stock split or consolidation
|
-746,064 vol |
0 | |
Filed 2023-07-14 19:28 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+14,517 vol |
14,517 | |
Filed 2023-07-14 19:27 Tx date 2023-07-10 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-87,100 vol |
0 | |
Filed 2022-09-29 13:52 Tx date 2022-09-28 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+45,000 vol |
87,100 | |
Filed 2021-11-15 14:11 Tx date 2021-11-12 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+42,100 vol |
42,100 | |
Filed 2021-11-15 14:10 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-09-07 09:53 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Kottayil Grace Pharma LLC (Control or Direction)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
746,064 | ||
Filed 2021-09-03 14:24 Tx date 2021-08-27 |
$ACST
Acasti Pharma Inc. |
Kavuru, Vimal
4 - Director of Issuer
Holder: Shore Pharma LLC (Indirect Ownership)
|
Common Shares (Actions de catégorie A)
00 - Opening Balance-Initial SEDI Report
|
3,070,229 |